Detection of human papillomavirus type 56 in Bowen's disease involving the nail matrix

A Shimizu1, A Tamura, M Abe

  • 1Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. ashimizu@med.gunma-u.ac.jp

Abstract

Insights

Human papillomavirus (HPV) type 56 DNA was detected in three of five patients with Bowen's disease of the nail apparatus. HPV 56 may play a role in nail matrix carcinogenesis, particularly in cases with longitudinal pigmentation.

Area of Science:

  • Dermatology
  • Oncology
  • Virology

Background:

  • Bowen's disease of the nail apparatus is a rare condition.
  • Limited data exists on human papillomavirus (HPV) prevalence in this disease.

Purpose of the Study:

  • To investigate the association between HPV and Bowen's disease of the nail apparatus.
  • To clarify the role of HPV in the pathogenesis of this rare nail condition.

Main Methods:

  • Clinical, virological, and histological examination of five patients with Bowen's disease of the nail apparatus.
  • Polymerase chain reaction (PCR) and DNA sequencing to detect and analyze HPV DNA in skin lesions.
  • In situ hybridization to determine the histological localization of HPV DNA.

Main Results:

  • HPV DNA was detected in three out of five patients using PCR; sequencing identified HPV type 56.
  • HPV-positive patients commonly presented with longitudinal melanonychia.
  • HPV DNA was localized to keratinocyte nuclei, with variations in HPV 56 sequences observed.

Conclusions:

  • Human papillomavirus type 56 is implicated in the carcinogenesis of Bowen's disease affecting the nail matrix.
  • HPV 56 may be a contributing factor in nail matrix tumors presenting with longitudinal pigmentation.